These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19333752)

  • 1. Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
    Torres D; Rashid MU; ; Seidel-Renkert A; Weitzel JN; Briceno I; Hamann U
    Breast Cancer Res Treat; 2009 Oct; 117(3):679-81. PubMed ID: 19333752
    [No Abstract]   [Full Text] [Related]  

  • 2. High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
    Torres D; Rashid MU; Gil F; Umana A; Ramelli G; Robledo JF; Tawil M; Torregrosa L; Briceno I; Hamann U
    Breast Cancer Res Treat; 2007 Jun; 103(2):225-32. PubMed ID: 17080309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
    Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 disease-associated haplotypes in Singapore Malay women with early-onset breast/ovarian cancer.
    Ali AB; Iau PT; Putti TC; Sng JH
    Breast Cancer Res Treat; 2007 Sep; 104(3):351-3. PubMed ID: 17406974
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
    Weitzel JN; Clague J; Martir-Negron A; Ogaz R; Herzog J; Ricker C; Jungbluth C; Cina C; Duncan P; Unzeitig G; Saldivar JS; Beattie M; Feldman N; Sand S; Port D; Barragan DI; John EM; Neuhausen SL; Larson GP
    J Clin Oncol; 2013 Jan; 31(2):210-6. PubMed ID: 23233716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania.
    Janavicius R; Pepalyte I; Kucinskas V
    Breast Cancer Res Treat; 2009 Sep; 117(2):467-9. PubMed ID: 18763032
    [No Abstract]   [Full Text] [Related]  

  • 7. BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.
    Malacrida S; Agata S; Callegaro M; Casella C; Barana D; Scaini MC; Manoukian S; Oliani C; Radice P; Barile M; Menin C; D'Andrea E; Montagna M
    J Clin Oncol; 2008 Jan; 26(1):26-31. PubMed ID: 18165637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.
    da Costa EC; Vargas FR; Moreira AS; Lourenço JJ; Caleffi M; Ashton-Prolla P; Martins Moreira MA
    Cancer Genet Cytogenet; 2008 Jul; 184(1):62-6. PubMed ID: 18558292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary cancer of the breast and ovary].
    Díez Gibert O; Machuca Cordano I; Navarro MA
    Med Clin (Barc); 1998 Feb; 110(5):199. PubMed ID: 9547728
    [No Abstract]   [Full Text] [Related]  

  • 10. BRCA1 IVS2-2delA: a deleterious mutation in a family of Asian descent.
    Martin ES; Croce CM; Biggs DD; Martin SE
    Cancer Genet Cytogenet; 2004 Apr; 150(2):173-5. PubMed ID: 15066328
    [No Abstract]   [Full Text] [Related]  

  • 11. Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.
    Fragoso-Ontiveros V; Velázquez-Aragón JA; Nuñez-Martínez PM; de la Luz Mejía-Aguayo M; Vidal-Millán S; Pedroza-Torres A; Sánchez-Contreras Y; Ramírez-Otero MA; Muñiz-Mendoza R; Domínguez-Ortíz J; Wegman-Ostrosky T; Bargalló-Rocha JE; Gallardo-Rincón D; Reynoso-Noveron N; Arriaga-Canon C; Meneses-García A; Herrera-Montalvo LA; Alvarez-Gomez RM
    PLoS One; 2019; 14(9):e0222709. PubMed ID: 31545835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of miscarriage and BRCA carrier status in Pakistani breast/ovarian cancer patients with a history of parental consanguinity.
    Rashid MU; Torres D; Rasheed F; Sultan F; Shakoori AR; Amin A; Schlaefer K; Hamann U
    Breast Cancer Res Treat; 2009 Jul; 116(1):211-3. PubMed ID: 18574689
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing.
    Yap KP; Ang P; Lim IH; Ho GH; Lee AS
    Clin Genet; 2006 Jul; 70(1):80-2. PubMed ID: 16813611
    [No Abstract]   [Full Text] [Related]  

  • 15. BRCA1 c.2845insA is a recurring mutation with a founder effect in Singapore Malay women with early onset breast/ovarian cancer.
    Sng JH; Ali AB; Lee SC; Zahar D; Wong JE; Blake V; Sharif A; Cross G; Iau PT
    J Med Genet; 2003 Oct; 40(10):e117. PubMed ID: 14569140
    [No Abstract]   [Full Text] [Related]  

  • 16. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

  • 17. BRCA1 c.2845insA is a founder mutation in Singaporean Malay women with early onset breast/ovarian cancer.
    Sng JH; Ali AB; Lee SC; Zahar D; Wong JE; Cross G; Iau PT
    Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S53-5. PubMed ID: 14968737
    [No Abstract]   [Full Text] [Related]  

  • 18. BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder.
    Makriyianni I; Hamel N; Ward S; Foulkes WD; Graw S
    J Med Genet; 2005 May; 42(5):e27. PubMed ID: 15863659
    [No Abstract]   [Full Text] [Related]  

  • 19. The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.
    Palanca S; de Juan I; Perez-Simó G; Barragán E; Chirivella I; Martínez E; Fuster O; Bolufer P
    Fam Cancer; 2013 Mar; 12(1):119-23. PubMed ID: 23117300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Popularity of breast cancer program leads to referral protocols in BC.
    Kent H
    CMAJ; 1998 Oct; 159(7):832-3. PubMed ID: 9805033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.